APA (7th ed.) Citation

MM, B., SJ, L., LL, S., A, M., TL, H., & LS, C. (2021). Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes. Journal of neuroinflammation, 18(1), 67. https://doi.org/10.1186/s12974-021-02118-x

Chicago Style (17th ed.) Citation

MM, Boyd, Litscher SJ, Seitz LL, Messing A, Hagemann TL, and Collier LS. "Pexidartinib Treatment in Alexander Disease Model Mice Reduces Macrophage Numbers and Increases Glial Fibrillary Acidic Protein Levels, yet Has Minimal Impact on Other Disease Phenotypes." Journal of Neuroinflammation 18, no. 1 (2021): 67. https://doi.org/10.1186/s12974-021-02118-x.

MLA (9th ed.) Citation

MM, Boyd, et al. "Pexidartinib Treatment in Alexander Disease Model Mice Reduces Macrophage Numbers and Increases Glial Fibrillary Acidic Protein Levels, yet Has Minimal Impact on Other Disease Phenotypes." Journal of Neuroinflammation, vol. 18, no. 1, 2021, p. 67, https://doi.org/10.1186/s12974-021-02118-x.